Compare Allstate Corp (ALL) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allstate Corp vs Quest Diagnostics Inc — how do they compare? Allstate Corp trades at $262 (market cap $66.31B), while Quest Diagnostics Inc trades at $237.5 (market cap $26.21B). The key difference: Allstate Corp is far larger — about 2.5× Quest Diagnostics Inc's market cap, and Allstate Corp pays the higher dividend (1.65%). Which is the better fit depends on your goals.
| ALL | DGX | |
|---|---|---|
Market Cap | $66.31B | $26.21B |
Sector | Financials | Health |
52-Week High | $275.11 | $238.50 |
52-Week Low | $190.00 | $173.49 |
Enterprise Value | $74.96B | $31.97B |
Dividend Yield | 1.65% | 1.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Allstate Corp
On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.
Read more on ALL →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
